Abstract
We describe two patients who developed levodopa-responsive parkinsonism without dementia at least 4 years after beginning chronic valproate (VPA) treatment for seizures. Parkinsonism disappeared in less than 3 months after VPA substitution with carbamazepine.
MeSH terms
-
Aged
-
Anticonvulsants / adverse effects*
-
Antiparkinson Agents / therapeutic use
-
Carbidopa / therapeutic use
-
Female
-
Humans
-
Levodopa / therapeutic use
-
Male
-
Middle Aged
-
Parkinson Disease, Secondary / chemically induced*
-
Parkinson Disease, Secondary / drug therapy
-
Remission Induction
-
Seizures / prevention & control
-
Valproic Acid / adverse effects*
Substances
-
Anticonvulsants
-
Antiparkinson Agents
-
Levodopa
-
Valproic Acid
-
Carbidopa